Arcus Biosciences, Inc.

RCUS · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$238,000$248,000$192,000$150,000
Short-Term Investments$593,000$663,000$805,000$828,000
Receivables$14,000$20,000$21,000$25,000
Inventory$0$0$0$0
Other Curr. Assets$12,000$15,000$13,000$13,000
Total Curr. Assets$857,000$946,000$1,031,000$1,016,000
Property Plant & Equip (Net)$42,000$44,000$46,000$47,000
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$10,000$16,000$8,000$14,000
Tax Assets$0$0$0$0
Other NC Assets$65,000$69,000$71,000$73,000
Total NC Assets$117,000$129,000$125,000$134,000
Other Assets$0$0$0$0
Total Assets$974,000$1,075,000$1,156,000$1,150,000
Liabilities
Payables$42,000$29,000$22,000$18,000
Short-Term Debt$13,000$12,000$12,000$12,000
Tax Payable$0$0$0$1,000
Deferred Revenue$52,000$71,000$72,000$85,000
Other Curr. Liab.$128,000$98,000$86,000$110,000
Total Curr. Liab.$235,000$210,000$192,000$226,000
LT Debt$98,000$97,000$48,000$48,000
Deferred Rev, NC$53,000$60,000$219,000$234,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$152,000$159,000$166,000$157,000
Total NC Liab.$303,000$316,000$433,000$439,000
Other Liabilities$0$0$0$0
Cap. Leases$13,000$12,000$12,000$12,000
Total Liabilities$538,000$526,000$625,000$665,000
Equity
Pref Stock$0$0$0$0
Common Stock$1,815,000$1,793,000$1,775,000$1,617,000
Retained Earnings-$1,379,000-$1,244,000-$1,244,000-$1,132,000
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity$436,000$549,000$531,000$485,000
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$974,000$1,075,000$1,156,000$1,150,000
Net Debt-$127,000-$139,000-$132,000-$90,000
Arcus Biosciences, Inc. (RCUS) Financial Statements & Key Stats | AlphaPilot